Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists

Using the available structural information of the chemokine receptor CXCR4, we present hit finding and hit exploration studies that make use of virtual fragment screening, design, synthesis and structure-activity relationship (SAR) studies. Fragment 2 was identified as virtual screening hit and used...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of medicinal chemistry Vol. 162; pp. 631 - 649
Main Authors Adlere, I., Sun, S., Zarca, A., Roumen, L., Gozelle, M., Viciano, C. Perpiñá, Caspar, B., Arimont, M., Bebelman, J.P., Briddon, S.J., Hoffmann, C., Hill, S.J., Smit, M.J., Vischer, H.F., Wijtmans, M., de Graaf, C., de Esch, I.J.P., Leurs, R.
Format Journal Article
LanguageEnglish
Published ISSY-LES-MOULINEAUX Elsevier Masson SAS 15.01.2019
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Using the available structural information of the chemokine receptor CXCR4, we present hit finding and hit exploration studies that make use of virtual fragment screening, design, synthesis and structure-activity relationship (SAR) studies. Fragment 2 was identified as virtual screening hit and used as a starting point for the exploration of 31 N-substituted piperidin-4-yl-methanamine derivatives to investigate and improve the interactions with the CXCR4 binding site. Additionally, subtle structural ligand changes lead to distinct interactions with CXCR4 resulting in a full to partial displacement of CXCL12 binding and competitive and/or non-competitive antagonism. Three-dimensional quantitative structure-activity relationship (3D-QSAR) and binding model studies were used to identify important hydrophobic interactions that determine binding affinity and indicate key ligand-receptor interactions. [Display omitted] •A structure-based virtual screening was used to find fragment-like CXCR4 ligands.•Several inhibitors show binding affinity comparable to hallmark antagonist AMD3100.•Key ligands have distinct competition modes with endogenous chemokine CXCL12.•SAR, 3D-QSAR and predicted binding modes of the hit compounds were analyzed.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0223-5234
1768-3254
DOI:10.1016/j.ejmech.2018.10.060